Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Biocompatible Injectable Magnetic Hydrogel Formed by Dynamic Coordination Network.

Shi L, Zeng Y, Zhao Y, Yang B, Ossipov D, Tai CW, Dai J, Xu C.

ACS Appl Mater Interfaces. 2019 Nov 13. doi: 10.1021/acsami.9b17627. [Epub ahead of print]

PMID:
31718134
2.

Hyaluronan-based delivery of therapeutic oligonucleotides for treatment of human diseases.

Ossipov DA.

Expert Opin Drug Deliv. 2019 Jun;16(6):621-637. doi: 10.1080/17425247.2019.1617693. Epub 2019 May 20.

PMID:
31072142
3.

Self-Healing Polymeric Hydrogel Formed by Metal-Ligand Coordination Assembly: Design, Fabrication, and Biomedical Applications.

Shi L, Ding P, Wang Y, Zhang Y, Ossipov D, Hilborn J.

Macromol Rapid Commun. 2019 Apr;40(7):e1800837. doi: 10.1002/marc.201800837. Epub 2019 Jan 23. Review.

PMID:
30672628
4.

A Modular Approach to Sensitized Two-Photon Patterning of Photodegradable Hydrogels.

Lunzer M, Shi L, Andriotis OG, Gruber P, Markovic M, Thurner PJ, Ossipov D, Liska R, Ovsianikov A.

Angew Chem Int Ed Engl. 2018 Nov 12;57(46):15122-15127. doi: 10.1002/anie.201808908. Epub 2018 Oct 18.

5.

Injectable hyaluronic acid hydrogels with the capacity for magnetic resonance imaging.

Bermejo-Velasco D, Dou W, Heerschap A, Ossipov D, Hilborn J.

Carbohydr Polym. 2018 Oct 1;197:641-648. doi: 10.1016/j.carbpol.2018.06.028. Epub 2018 Jun 7.

PMID:
30007657
6.

Moldable Hyaluronan Hydrogel Enabled by Dynamic Metal-Bisphosphonate Coordination Chemistry for Wound Healing.

Shi L, Zhao Y, Xie Q, Fan C, Hilborn J, Dai J, Ossipov DA.

Adv Healthc Mater. 2018 Mar;7(5). doi: 10.1002/adhm.201700973. Epub 2017 Dec 27.

PMID:
29281172
7.

A new synthetic granular calcium phosphate compound induces new bone in a sinus lift rabbit model.

Trbakovic A, Hedenqvist P, Mellgren T, Ley C, Hilborn J, Ossipov D, Ekman S, Johansson CB, Jensen-Waern M, Thor A.

J Dent. 2018 Mar;70:31-39. doi: 10.1016/j.jdent.2017.12.009. Epub 2017 Dec 16.

PMID:
29258851
8.

Enzymatic degradation of hyaluronan hydrogels with different capacity for in situ bio-mineralization.

Shi L, Zhang Y, Ossipov D.

Biopolymers. 2018 Feb;109(2). doi: 10.1002/bip.23090. Epub 2017 Nov 27.

PMID:
29178472
9.

Light-activatable prodrugs based on hyaluronic acid biomaterials.

Ossipov DA, Romero AB, Ossipova E.

Carbohydr Polym. 2018 Jan 15;180:145-155. doi: 10.1016/j.carbpol.2017.10.028. Epub 2017 Oct 6.

PMID:
29103490
10.

Self-assembled hyaluronic acid nanoparticles for controlled release of agrochemicals and diosgenin.

Quiñones JP, Brüggemann O, Covas CP, Ossipov DA.

Carbohydr Polym. 2017 Oct 1;173:157-169. doi: 10.1016/j.carbpol.2017.05.048. Epub 2017 May 31.

PMID:
28732854
11.

Exploiting Bisphosphonate-Bioactive-Glass Interactions for the Development of Self-Healing and Bioactive Composite Hydrogels.

Diba M, An J, Schmidt S, Hembury M, Ossipov D, Boccaccini AR, Leeuwenburgh SC.

Macromol Rapid Commun. 2016 Dec;37(23):1952-1959. doi: 10.1002/marc.201600353. Epub 2016 Sep 19.

PMID:
27643998
12.

Convergent in situ assembly of injectable lipogel for enzymatically controlled and targeted delivery of hydrophilic molecules.

Yang X, Shi L, Guo X, Gao J, Ossipov D.

Carbohydr Polym. 2016 Dec 10;154:62-9. doi: 10.1016/j.carbpol.2016.08.028. Epub 2016 Aug 10.

PMID:
27577897
13.

"Smart" drug loaded nanoparticle delivery from a self-healing hydrogel enabled by dynamic magnesium-biopolymer chemistry.

Shi L, Han Y, Hilborn J, Ossipov D.

Chem Commun (Camb). 2016 Sep 25;52(74):11151-4. doi: 10.1039/c6cc05565f. Epub 2016 Aug 23.

PMID:
27550535
14.

Hyaluronic acid-fibrin interpenetrating double network hydrogel prepared in situ by orthogonal disulfide cross-linking reaction for biomedical applications.

Zhang Y, Heher P, Hilborn J, Redl H, Ossipov DA.

Acta Biomater. 2016 Jul 1;38:23-32. doi: 10.1016/j.actbio.2016.04.041. Epub 2016 Apr 28.

PMID:
27134013
15.

Hyaluronic Acid Hydrogels Formed in Situ by Transglutaminase-Catalyzed Reaction.

Ranga A, Lutolf MP, Hilborn J, Ossipov DA.

Biomacromolecules. 2016 May 9;17(5):1553-60. doi: 10.1021/acs.biomac.5b01587. Epub 2016 Apr 8.

PMID:
27014785
16.

Non-invasive in vitro and in vivo monitoring of degradation of fluorescently labeled hyaluronan hydrogels for tissue engineering applications.

Zhang Y, Rossi F, Papa S, Violatto MB, Bigini P, Sorbona M, Redaelli F, Veglianese P, Hilborn J, Ossipov DA.

Acta Biomater. 2016 Jan;30:188-198. doi: 10.1016/j.actbio.2015.11.053. Epub 2015 Nov 24.

PMID:
26621694
17.

Control of growth factor binding and release in bisphosphonate functionalized hydrogels guides rapid differentiation of precursor cells in vitro.

Kootala S, Zhang Y, Ghalib S, Tolmachev V, Hilborn J, Ossipov DA.

Biomater Sci. 2016 Feb;4(2):250-4. doi: 10.1039/c5bm00355e.

PMID:
26610690
18.

Correction: Bisphosphonate-functionalized hyaluronic acid showing selective affinity for osteoclasts as a potential treatment for osteoporosis.

Kootala S, Ossipov D, van den Beucken JJ, Leeuwenburgh S, Hilborn J.

Biomater Sci. 2015 Oct 15;3(10):1414. doi: 10.1039/c5bm90034d. Epub 2015 Aug 6.

PMID:
26247158
19.

In situ forming interpenetrating hydrogels of hyaluronic acid hybridized with iron oxide nanoparticles.

Kheirabadi M, Shi L, Bagheri R, Kabiri K, Hilborn J, Ossipov DA.

Biomater Sci. 2015 Nov;3(11):1466-74. doi: 10.1039/c5bm00150a.

PMID:
26247066
20.

Bisphosphonate-functionalized hyaluronic acid showing selective affinity for osteoclasts as a potential treatment for osteoporosis.

Kootala S, Ossipov D, van den Beucken JJ, Leeuwenburgh S, Hilborn J.

Biomater Sci. 2015 Aug;3(8):1197-207. doi: 10.1039/c5bm00096c. Epub 2015 Jun 24. Erratum in: Biomater Sci. 2015 Oct 15;3(10):1414.

PMID:
26222035
21.

Bisphosphonate-modified biomaterials for drug delivery and bone tissue engineering.

Ossipov DA.

Expert Opin Drug Deliv. 2015;12(9):1443-58. doi: 10.1517/17425247.2015.1021679. Epub 2015 Mar 5. Review.

PMID:
25739860
22.

Hydrogel patterning by diffusion through the matrix and subsequent light-triggered chemical immobilization.

Yi Z, Zhang Y, Kootala S, Hilborn J, Ossipov DA.

ACS Appl Mater Interfaces. 2015 Jan 21;7(2):1194-206. doi: 10.1021/am506926w. Epub 2015 Jan 9.

PMID:
25575380
23.

Injectable hyaluronic acid hydrogel for 19F magnetic resonance imaging.

Yang X, Sun Y, Kootala S, Hilborn J, Heerschap A, Ossipov D.

Carbohydr Polym. 2014 Sep 22;110:95-9. doi: 10.1016/j.carbpol.2014.03.070. Epub 2014 Apr 2.

PMID:
24906733
24.

Injectable in situ forming hybrid iron oxide-hyaluronic acid hydrogel for magnetic resonance imaging and drug delivery.

Zhang Y, Sun Y, Yang X, Hilborn J, Heerschap A, Ossipov DA.

Macromol Biosci. 2014 Sep;14(9):1249-59. doi: 10.1002/mabi.201400117. Epub 2014 May 23.

PMID:
24863175
25.

Self-healing hybrid nanocomposites consisting of bisphosphonated hyaluronan and calcium phosphate nanoparticles.

Nejadnik MR, Yang X, Bongio M, Alghamdi HS, van den Beucken JJ, Huysmans MC, Jansen JA, Hilborn J, Ossipov D, Leeuwenburgh SC.

Biomaterials. 2014 Aug;35(25):6918-29. doi: 10.1016/j.biomaterials.2014.05.003. Epub 2014 May 24.

PMID:
24862440
26.

Rapid screening of mineralization capacity of biomaterials by means of quantification of enzymatically deposited calcium phosphate.

Nijhuis AW, Takemoto S, Nejadnik MR, Li Y, Yang X, Ossipov DA, Hilborn J, Mikos AG, Yoshinari M, Jansen JA, Leeuwenburgh SC.

Tissue Eng Part C Methods. 2014 Oct;20(10):838-50. doi: 10.1089/ten.TEC.2013.0334. Epub 2014 May 1.

PMID:
24650236
27.

Bisphosphonate-linked hyaluronic acid hydrogel sequesters and enzymatically releases active bone morphogenetic protein-2 for induction of osteogenic differentiation.

Hulsart-Billström G, Yuen PK, Marsell R, Hilborn J, Larsson S, Ossipov D.

Biomacromolecules. 2013 Sep 9;14(9):3055-63. doi: 10.1021/bm400639e. Epub 2013 Aug 28.

PMID:
23947433
28.

Calcium-mediated secondary cross-linking of bisphosphonated oligo(poly(ethylene glycol) fumarate) hydrogels.

Nejadnik MR, Yang X, Mimura T, Birgani ZT, Habibovic P, Itatani K, Jansen JA, Hilborn J, Ossipov D, Mikos AG, Leeuwenburgh SC.

Macromol Biosci. 2013 Oct;13(10):1308-13. doi: 10.1002/mabi.201300117. Epub 2013 Jul 16.

PMID:
23861228
29.

Improving the osteogenic potential of BMP-2 with hyaluronic acid hydrogel modified with integrin-specific fibronectin fragment.

Kisiel M, Martino MM, Ventura M, Hubbell JA, Hilborn J, Ossipov DA.

Biomaterials. 2013 Jan;34(3):704-12. doi: 10.1016/j.biomaterials.2012.10.015. Epub 2012 Oct 24.

PMID:
23103154
30.

Minimally invasive mandibular bone augmentation using injectable hydrogels.

Martínez-Sanz E, Varghese OP, Kisiel M, Engstrand T, Reich KM, Bohner M, Jonsson KB, Kohler T, Müller R, Ossipov DA, Hilborn J.

J Tissue Eng Regen Med. 2012 Dec;6 Suppl 3:s15-23. doi: 10.1002/term.1593. Epub 2012 Sep 3.

PMID:
22941759
31.

Synthesis of guanidinium-modified hyaluronic Acid hydrogel.

Varghese OP, Kisiel M, Martínez-Sanz E, Ossipov DA, Hilborn J.

Macromol Rapid Commun. 2010 Jul 1;31(13):1175-80. doi: 10.1002/marc.200900906. Epub 2010 May 17.

PMID:
21590872
32.

Bone reservoir: Injectable hyaluronic acid hydrogel for minimal invasive bone augmentation.

Martínez-Sanz E, Ossipov DA, Hilborn J, Larsson S, Jonsson KB, Varghese OP.

J Control Release. 2011 Jun 10;152(2):232-40. doi: 10.1016/j.jconrel.2011.02.003. Epub 2011 Feb 22.

PMID:
21315118
33.

Modular approach to functional hyaluronic acid hydrogels using orthogonal chemical reactions.

Ossipov DA, Yang X, Varghese O, Kootala S, Hilborn J.

Chem Commun (Camb). 2010 Nov 28;46(44):8368-70. doi: 10.1039/c0cc03055d. Epub 2010 Oct 5.

PMID:
20922254
34.

Functionalization of hyaluronic acid with chemoselective groups via a disulfide-based protection strategy for in situ formation of mechanically stable hydrogels.

Ossipov DA, Piskounova S, Varghese OP, Hilborn J.

Biomacromolecules. 2010 Sep 13;11(9):2247-54. doi: 10.1021/bm1007986.

PMID:
20704177
35.

Bone morphogenetic protein-2 delivered by hyaluronan-based hydrogel induces massive bone formation and healing of cranial defects in minipigs.

Docherty-Skogh AC, Bergman K, Waern MJ, Ekman S, Hultenby K, Ossipov D, Hilborn J, Bowden T, Engstrand T.

Plast Reconstr Surg. 2010 May;125(5):1383-92. doi: 10.1097/PRS.0b013e3181d629dc.

PMID:
20440158
36.

Nanostructured hyaluronic acid-based materials for active delivery to cancer.

Ossipov DA.

Expert Opin Drug Deliv. 2010 Jun;7(6):681-703. doi: 10.1517/17425241003730399. Review.

PMID:
20367530
37.

In situ cross-linkable high molecular weight hyaluronan-bisphosphonate conjugate for localized delivery and cell-specific targeting: a hydrogel linked prodrug approach.

Varghese OP, Sun W, Hilborn J, Ossipov DA.

J Am Chem Soc. 2009 Jul 1;131(25):8781-3. doi: 10.1021/ja902857b.

PMID:
19499915
38.

Injectable cell-free template for bone-tissue formation.

Bergman K, Engstrand T, Hilborn J, Ossipov D, Piskounova S, Bowden T.

J Biomed Mater Res A. 2009 Dec 15;91(4):1111-8. doi: 10.1002/jbm.a.32289.

PMID:
19107794
39.

A novel stem loop control element-dependent UGA read-through system without translational selenocysteine incorporation in Drosophila.

Hirosawa-Takamori M, Ossipov D, Novoselov SV, Turanov AA, Zhang Y, Gladyshev VN, Krol A, Vorbrüggen G, Jäckle H.

FASEB J. 2009 Jan;23(1):107-13. doi: 10.1096/fj.08-116640. Epub 2008 Sep 4.

40.

RNA cleavage by 2,9-diamino-1,10-phenanthroline PNA conjugates.

Murtola M, Ossipov D, Sandbrink J, Strömberg R.

Nucleosides Nucleotides Nucleic Acids. 2007;26(10-12):1479-83.

PMID:
18066810
41.

Monoclonal antibody blockade of the human Eag1 potassium channel function exerts antitumor activity.

Gómez-Varela D, Zwick-Wallasch E, Knötgen H, Sánchez A, Hettmann T, Ossipov D, Weseloh R, Contreras-Jurado C, Rothe M, Stühmer W, Pardo LA.

Cancer Res. 2007 Aug 1;67(15):7343-9.

42.
43.

Investigation of potential RNA bulge stabilizing elements.

Sandbrink J, Ossipov D, Aström H, Strömberg R.

J Mol Recognit. 2005 Jul-Aug;18(4):318-26. Erratum in: J Mol Recognit. 2007 Jul-Aug;20(4):275.

PMID:
15756640
44.
45.

Synthesis of [Ru(phen)(2)dppz](2+)-tethered oligo-DNA and studies on the metallointercalation mode into the DNA duplex.

Ossipov D, Pradeepkumar PI, Holmer M, Chattopadhyaya J.

J Am Chem Soc. 2001 Apr 18;123(15):3551-62.

PMID:
11472126
46.

Yeast ER-Golgi v-SNAREs Bos1p and Bet1p differ in steady-state localization and targeting.

Ossipov D, Schröder-Köhne S, Schmitt HD.

J Cell Sci. 1999 Nov;112 ( Pt 22):4135-42.

47.

Recycling of the yeast v-SNARE Sec22p involves COPI-proteins and the ER transmembrane proteins Ufe1p and Sec20p.

Ballensiefen W, Ossipov D, Schmitt HD.

J Cell Sci. 1998 Jun;111 ( Pt 11):1507-20.

48.

Sec12p requires Rer1p for sorting to coatomer (COPI)-coated vesicles and retrieval to the ER.

Boehm J, Letourneur F, Ballensiefen W, Ossipov D, Démollière C, Schmitt HD.

J Cell Sci. 1997 Apr;110 ( Pt 8):991-1003.

49.

Interactions between Paramecium bursaria (Protozoa, Ciliophora, Hymenostomatida) and their nuclear symbionts: I. Phenomenon of symbiogenic lysis of the bacterium Holospora acuminata.

Ossipov DV, Skoblo II, Borchsenius ON, Lebedeva NA.

Eur J Protistol. 1993 Feb 19;29(1):61-71. doi: 10.1016/S0932-4739(11)80298-1. Epub 2011 Nov 2.

PMID:
23195446

Supplemental Content

Loading ...
Support Center